- Uses a new, consistent format for each drug class: overview and guidelines for use, mechanisms of action, differences among drugs in class, data for use, side effects, and drug interactions.
- Covers key topics such as new ESC and NLA guidelines, advances in lipid-lowering therapy, new diabetes drugs that improve cardiovascular outcomes, obesity drugs and cardiovascular and metabolic effects, drugs targeting inflammation, and combinations of antithrombotic therapies with analysis of risk-benefit.
- Provides guidance on how to effectively manage comorbid diseases.
- Contains dozens of unique “Opiegram” diagrams that demystify complex mechanisms of action and other drug processes―many updated to reflect current pathologic understanding of mechanisms.
- Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices
Product Details
- Paperback:720 pages
- ISBN-10:0323673619
- Item Weight:1.11 pounds
- ISBN-13:978-0323673617
- Publisher:Elsevier; 9th Edition (December 15, 2020)
- Language::English
Reviews
There are no reviews yet.